Protein 1 | Protein 2 | Combine Score |
---|---|---|
FAM86A | METTL10 | 0.875 |
METTL20 | METTL18 | 0.842 |
METTL10 | METTL20 | 0.811 |
METTL12 | METTL10 | 0.802 |
N6AMT2 | METTL10 | 0.8 |
FAM86A | METTL20 | 0.792 |
FAM86A | METTL18 | 0.791 |
METTL12 | METTL20 | 0.767 |
METTL10 | METTL18 | 0.767 |
N6AMT2 | METTL18 | 0.711 |
FAM86A | N6AMT2 | 0.681 |
FAM173A | METTL18 | 0.659 |
FAM173A | METTL12 | 0.656 |
FAM173A | N6AMT2 | 0.647 |
FAM173A | FAM86A | 0.629 |
N6AMT2 | METTL20 | 0.625 |
FAM173A | METTL20 | 0.61 |
FAM173A | METTL10 | 0.609 |
# | 254013 (METTL20) | 399818 (METTL10) | 751071 (METTL12) | 221143 (N6AMT2) |
---|---|---|---|---|
254013 (METTL20) | 1.00 | 0.68 | 0.73 | 0.68 |
399818 (METTL10) | 0.68 | 1.00 | 0.88 | 1.00 |
751071 (METTL12) | 0.73 | 0.88 | 1.00 | 0.88 |
221143 (N6AMT2) | 0.68 | 1.00 | 0.88 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FAM173A | Human | Blood | - | 3600 m | Native | upregulated | - | TMT-based proteomic analysis/LC-MS | Central Asia | Tibetans | - | High altitude native vs. low Lander | 30908922 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|
ID | GO ID | GO Term | GO Type |
---|---|---|---|
65990 | GO:0016021 | integral component of membrane | GOTERM_CC_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|